Read about our response to COVID-19

Key Initiatives

We believe we have an important role and responsibility in improving access to medicines, vaccines and quality health care worldwide, helping to reduce the burden of disease in the parts of the world that need it most.

We work in collaboration with local communities, governments, donors, patient organizations, health care professionals, nongovernmental organizations (NGOs), multilateral organizations, and others in the private sector to contribute our expertise and knowledge.

Active programs

The programs highlighted below are examples of our ongoing efforts:

ACS: Global Patient Navigation

Through a $2 million grant over five years (2019–2023), our company’s Foundation is helping the American Cancer Society (ACS) bring its expertise and experience in patient navigation to countries with a growing burden of cancer. This partnership aims to improve patient support and access to cancer care in sub-Saharan Africa and develop guidance to help low- and middle-income countries adopt similar models of care.

Addressing the Opioid Crisis in West Virginia 

Our company’s Foundation is supporting an initiative with Marshall Health through a $2 million grant over four years (2018–2021) to establish the Great Rivers Regional System for Addiction Care—a comprehensive program to address the opioid crisis in West Virginia.

Alliance to Advance Patient-Centered Cancer Care

Our company’s Foundation established the Alliance to Advance Patient-Centered Cancer Care to increase timely access to patient-centered care and reduce disparities in cancer care, especially for vulnerable and underserved populations in the United States.

Bridging the Gap: Reducing Disparities in Diabetes Care

Our company’s Foundation established Bridging the Gap to improve access to high-quality diabetes care and to reduce health disparities among vulnerable and underserved populations with type 2 diabetes in the United States.

HIV Care Connect

To help address persistent HIV disparities in the U.S., our company’s Foundation launched HIV Care Connect. This multi-site initiative aims to reduce disparities in access to care and improve health outcomes for people of color living with HIV in vulnerable and underserved communities in the Southeastern United States.

Improving Alzheimer’s Care in the U.S.

In 2018, our company’s Foundation launched several new programs that aim to improve the health and well-being of vulnerable individuals living with Alzheimer’s and their caregivers in the United States.

MECTIZAN® Donation Program

The MECTIZAN® (ivermectin) Donation Program is the longest-running disease-specific drug donation program and public-private partnership of its kind and is widely regarded as one of the most successful public-private health collaborations in the world.

MSD Medical Outreach Program (MMOP)

Our company’s Medical Outreach Program was established in 1958. It is the primary mechanism through which our company donates its pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency situations worldwide.

MSD Fellowship for Global Health

The MSD Fellowship for Global Health is a three-month, field-based corporate pro bono program designed to leverage the skills and talents of our employees worldwide.

MSD for Mothers

MSD for Mothers is a 10-year, $500 million initiative focused on improving the health and well-being of mothers before, during and after pregnancy and childbirth. Working together with committed partners, we believe we can help make pregnancy and childbirth a safe, healthy and joyful experience for women.

Project ECHO

To help build health care capacity and expand access to specialty care for complex or chronic conditions among underserved populations in Asia, our company’s Foundation established a partnership with Project ECHO (Extension for Community Healthcare Outcomes) to expand the replication of Project ECHO in India and Vietnam.

U.S. Patient Assistance Programs

More than 55 years ago, our company created our first U.S. patient assistance program (PAP) to keep affordable medicines within patients’ reach. Today, our patient assistance offerings include several programs.

Completed programs

The programs highlighted below are examples of our past programs and initiatives:

African Comprehensive HIV/AIDS Partnerships

Together with our company’s Foundation and the Bill & Melinda Gates Foundation, we established the African Comprehensive HIV/AIDS Partnerships (ACHAP) in 2002 to support Botswana, a country disproportionately affected by HIV/AIDS. To learn more, you may also read about ACHAP’s contributions to the fight against HIV/AIDS in Botswana.

Alliance to Reduce Disparities in Diabetes

To address the growing problem of health care disparities related to type 2 diabetes in the U.S. among low-income and underserved adult populations, our company’s Foundation launched the Alliance to Reduce Disparities in Diabetes, with a commitment of $15 million.

China-MSD HIV/AIDS Partnership

Our company’s Foundation committed $36 million to establish the China-MSD HIV/AIDS Partnership (C-MAP). C-MAP was the first large-scale public-private partnership between the Chinese government and a multinational company to focus on HIV/AIDS prevention and control.

HIV Care Collaborative

To help address remaining barriers to HIV care, especially among underserved populations, our company’s Foundation established the HIV Care Collaborative for Underserved Populations in the U.S. with the goal of connecting more people living with HIV to the care they need to stay healthy.

GARDASIL® Access Program

Through the GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] Access Program, we pledged to donate at least 3 million doses of GARDASIL for use in smaller-scale human papillomavirus (HPV) vaccination projects in eligible lowest-income countries around the world.